Rajnish Wellness P/B Ratio
Rajnish Wellness (RAJNISH) P/B ratio is 0.41 (Low), book value per share ₹10.10 vs Healthcare average P/B of -0.28 — Very Low - Significant discount to book value, potential distress or value opportunity. For live price, earnings yield and the full fundamental profile, see RAJNISH screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
RAJNISH P/B Ratio — Valuation Insights & Book Value Analysis
Rajnish Wellness price-to-book ratio interpretation, valuation status and historical context — current P/B 0.41 (Low). Review RAJNISH price earnings ratio to evaluate earnings-based valuation against sector peers.
- Stock appears undervalued with PB of 0.41, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Trading at premium to sector average PB of -0.28
Rajnish Wellness P/B Ratio Historical Trend
RAJNISH annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View RAJNISH annual price range for the annual high/low range and current price position.
RAJNISH Historical P/B Ratio — Book Value Per Share & Year-End Price
Rajnish Wellness annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.04 | ₹10.1 | ₹0.42 | ₹103 | Low |
| 2025 | 0.04 | ₹10.91 | ₹0.49 | ₹84 | Low |
| 2024 | 0.13 | ₹10.91 | ₹1.43 | ₹84 | Low |
| 2023 | 0.92 | ₹10.78 | ₹9.97 | ₹83 | Low |
| 2022 | 0.74 | ₹20.0 | ₹14.80 | ₹22 | Low |
RAJNISH vs Healthcare Peers — P/B Ratio Comparison
Rajnish Wellness P/B 0.41 vs Healthcare average -0.28, median 0.58 — range -14.47–1.14.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -14.47 | ₹18 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -5.09 | ₹36 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.22 | ₹72 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹115 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.5 | ₹44 | Low |